Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study

Journal of Affective Disorders

Volumn 186, Issue , 2015, Pages 376-382

  Loebel, Antony ^a   Siu, Cynthia ^b   Rajagopalan, Krithika ^a   Pikalov, Andrei ^a   Cucchiaro, Josephine ^a   Ketter, Terence A ^c  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b Deep Longevity   (Hong Kong)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar depression; Functional remission; Lurasidone; Recovery; Symptomatic remission

Indexed keywords

LURASIDONE; PLACEBO; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; DSM-IV-TR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SHEEHAN DISABILITY SCALE; UNSPECIFIED SIDE EFFECT; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; LONGITUDINAL STUDY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; TIME; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONGITUDINAL STUDIES; LURASIDONE HYDROCHLORIDE; MALE; MIDDLE AGED; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; TIME; TREATMENT OUTCOME;

EID: 84939146680     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.07.033     Document Type: Article

References (64)

1. R. Arbuckle, M.A. Frye, M. Brecher, and et al. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder Psychiatry Res. 165 2009 163 174
2. M. Berk, A. Brnabic, S. Dodd, K. Kelin, M. Tohen, G.S. Malhi, L. Berk, P. Conus, and P.D. McGorry Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention Bipolar Disord. 13 2011 87 98
3. R.V. Bijl, and A. Ravelli Current and residual functional disability associated with psychopathology, findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) Psychol. Med. 30 2000 657 668
4. J.R. Calabrese, R.M. Hirschfield, M.A. Frye, and M.L. Reed Impact of depressive symptoms compared with manic symptoms in bipolar disorder, results of a U.S. community-based sample J. Clin. Psychiatry 65 2004 1499 1504
5. J.R. Calabrese, P.E. Keck Jr. W. Macfadden, Z. Minkwitz, T.A. Ketter, R.H. Wiesler, A.J. Cutler, R. McCoy, E. Wilson, and J. Mullen A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am. J. Psychiatry 162 2005 1351 1360
6. L. Citrome, T.A. Ketter, J. Cucchiaro, and A. Loebel Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed J. Affect. Disord. 155 2014 20 27
7. W. Coryell, C. Turvey, J. Endicott, A.C. Leon, T. Mueller, D. Solomon, and M. Keller Bipolar I Affective disorder, predictors of outcome after 15 years J. Affect. Disord. 50 1998 109 116
8. R.B. D'Agostino, R.S. Vassan, M.J. Pencina, P.A. Wolf, M. Cobain, J.M. Massaro, and W.B. Kannel General cardiovascular risk profile for use in primary care, the Framingham Heart Study Circulation 117 2008 743 753
9. A. Fagiolini, R. Forgione, M. Maccari, A. Cuomo, M. Benedetto, M.C. Dell'Osso, F. Pellegini, and A. Rossi Prevalence, chronicity, burden and borders of bipolar disorder J. Affect. Disord. 148 2013 161 169
10. E. Frank, R. Prien, R.B. Jarrett, M.B. Keller, D.J. Kupfer, P.W. Lavoroni, A.J. Rush, and M.M. Weissman Conceptualization and rationale for consensus definitions of terms, in major depressive disorder, remission, recovery, relapse and recurrence Arch. Gen. Psychiatry 48 1991 851 855
11. S.N. Ghaemi, M.S. Lenox, and R.J. Baldessarini Effectiveness and safety of long-term antidepressant treatment in bipolar disorder J. Clin. Psychiatry 62 2001 565 569
12. S.N. Ghaemi, A.P. Wingo, M.A. Filkowski, and R.J. Baldessarini Long-term antidepressant treatment in bipolar disorder, meta-analysis of benefits and risks Acta Psychiatr. Scand. 118 2008 347 356
13. M.J. Gitlin, J. Swendson, T.L. Heller, and C. Hammen Relapse and impairment in bipolar disorder Am. J. Psychiatry 152 1995 1635 1649
14. J.F. Goldberg, and M. Harrow Consistency of remission and outcome in bipolar and unipolar mood disorders, a 10-year prospective study J. Affect. Disord. 81 2004 123 131
15. J.F. Goldberg, J.L. Garno, and M. Harrow Long-term remission and recovery in bipolar disorder: a review Curr. Psychiatry Rep. 7 2005 456 461
16. J.F. Goldberg, and M. Harrow Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders, a longitudinal analysis J. Affect. Disord. 89 2005 79 89
17. J.F. Goldberg, and M. Harrow A 15-year prospective follow-up of bipolar affective disorders, comparison with unipolar depression Bipolar Disord. 13 2011 155 163
18. J.M. Gonzalez, C.L. Bowden, N. Berman, E. Frank, M.S. Bauer, J.N. Kogan, M. Alegria, and D.J. Miklowitz One-year treatment outcome of African-American and Hispanic patients with bipolar II disorders in STEP-BD Psychiatr. Serv. 61 2010 164 172
19. P.D. Harvey, A.P. Wingo, K.E. Burdick, and R.J. Baldessarini Cognition and disability in bipolar disorder: lessons from schizophrenia and bipolar Bipolar Disord. 12 2010 364 375
20. N. Huxley, and R.J. Baldessarini Disability and its treatment in bipolar disorder patients Bipolar Disord. 9 2007 183 196
21. K.R. Jamison Suicide and bipolar disorder J. Clin. Psychiatry 61 Suppl. 9 2000 S47 S51
22. L.L. Judd, H.S. Akiskal, P.J. Schettler, J. Endicott, J. Maser, D.A. Solomon, A.C. Leon, J.A. Rice, and M.B. Keller The long-term natural history of the weekly symptomatic status of bipolar I disorder Arch. Gen. Psychiatry 59 2002 530 537
23. P.E. Keck Jr., S.L. McElroy, S.M. Strakowski, S.A. West, K.W. Sax, J.M. Hawkins, M.L. Bourne, and P. Haggard Twelve-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode Am. J. Psychiatry 155 1998 646 652
24. M.B. Keller, P.W. Lavori, J. Endicott, W. Coryell, and G.L. Kleman Double depression: a two year follow-up Am. J. Psychiatry 140 1983 689 694
25. T.A. Ketter, J.P. Houston, D.H. Adams, R.C. Risser, A.L. Meyers, D.J. Williamson, and M. Tohen Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes J. Clin. Psychiatry 67 2006 95 101
26. T.A. Ketter, K. Sarma, R. Silva, H. Kroger, J. Cucchiaro, and A. Loebel Lurasidone in the long-term treatment of patients with bipolar disorder: a 24-week open-label study Depression Anxiety 2015 (in press)
27. K. Kleine-Budde, E. Touil, J. Moock, A. Bramesfeld, W. Kawohl, and W. Rossler Cost of illness for bipolar disorder: a systematic review of the economic burden Bipolar Disord. 16 2014 337 353
28. J.N. Kogan, M.W. Otto, M.S. Bauer, E.B. Dennehy, D.J. Miklowitz, H.W. Zhang, T. Ketter, M.V. Rudorfer, S.R. Wisniewski, M.E. Thase, J. Calabrese, G.S. Sachs, and the Step-BD Investigators Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Bipolar Disord. 6 2004 460 469
29. D.J. Kupfer The increasing medical burden in bipolar disorder J. Am. Med. Assoc. 293 2005 2528 2530
30. R.W. Kupka, L.L. Altshuler, W.A. Nolan, T. Suppes, D.A. Luckenbaugh, G.S. Leverich, M.A. Frye, P.E. Keck Jr., S.L. McElroy, H. Grunze, and R.M. Post Three times more days depressed than manic or hypo-manic in both bipolar I and bipolar II disorders Bipolar Disord. 9 2007 531 535
31. G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, P.E. Keck Jr., S.L. McElroy, K.D. Denicoff, G. Obrocea, W.A. Nolen, R. Kupka, J. Walden, H. Grunze, S. Perez, D.A. Luckenbaugh, and R.M. Post Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network J. Clin. Psychiatry 64 2003 506 515
32. A.C. Leon, M. Olfson, L. Portera, L. Farber, and D.V. Sheehan Assessing psychiatric impairment in primary care with the Sheehan Disability Scale Int. J. Psychiatry Med. 27 1997 93 105
33. A. Loebel, J. Cucchiaro, R. Silva, H. Kroger, J. Hsu, K. Sarma, and G. Sachs Lurasidone monotherapy in the treatment of bipolar I depression, a randomized, double-blind, placebo-controlled study Am. J. Psychiatry 171 2014 160 168
34. A. Loebel, J. Cucchiaro, R. Silva, H. Kroger, K. Sarma, J. Xu, and J.R. Calabrese Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression, a randomized, double-blind, placebo-controlled study Am. J. Psychiatry 171 2014 169 177
35. I. Lombardo, G. Sachs, S. Kolluri, C. Kremer, and R. Yang Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outer patients with bipolar I depression, did baseline characteristics impact trial outcome J. Clin. Psycopharmacol. 32 2012 470 478
36. G.M. MacQueen, L.T. Young, and R.T. Joffe A review of psychosocial outcome in patients with bipolar disorder Acta Psychiatr. Scand. 103 2001 163 170
37. M. Mancini, D.V. Sheehan, K. Demyttenaere, M. Amore, W. Deberdt, D. Quail, and D. Sagman Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale, pooled analysis of data from six randomized, double-blind, placebo-controlled clinical trials Int. Clin. Psychopharmacol. 27 2012 298 309
38. K.R. Merikangas, H.S. Akiskal, J. Angst, P.E. Greenberg, R.M. Hirschfeld, M. Petukhova, and R.C. Kessler Life time and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch. Gen. Psychiatry 64 2007 543 552
39. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389
40. R.H. Perlis, M.J. Ostacher, K. Patel, L.B. Marangell, H. Zhang, S.R. Wisniewski, T.A. Ketter, D.J. Miklowitz, M.W. Otto, L. Gyulai, N.A. Reilly-Harrington, A.A. Nierenberg, and G.S. Sachs Predictors of occurrence of bipolar disorder, primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Am. J. Psychiatry 163 2006 217 224
41. D.G. Robinson, M.G. Woerner, M. McMeniman, A. Mandelowitz, and R.M. Bilder Symptomatic and functional recovery from a first-episode of schizophrenia or schizoaffective disorder Am. J. Psychiatry 161 2004 473 479
42. A.R. Rosa, J.S. Moreno, A. Martinez-Aran, and et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder Clin. Pract. Epidemiol. Ment. Health 3 2007 5
43. Sachs, G., Altshuler, L., Ketter, T., Suppes, T., Rasgon, N., Frye, M., Collins, M., 2001. Divalproex versus Placebo for the Treatment of Biolar Depression. Presented at the 40th Annual Meeting of the American College of Neuropsychopharmacology December 9-13, 2001. San Juan, Puerto Rico.
44. G.S. Sachs, K.S. Ice, P.B. Chappell, J.H. Schwartz, O. Gurtovaya, D.G. Vanderburg, and B. Kasuba Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder, a randomized, double-blind, placebo-controlled trial J. Clin. Psychiatry 72 2011 1413 1422
45. D.V. Sheehan, K. Hamett-Sheehan, and B.A. Raj The measurement of disability Int. Clin. Psychopharmacol. 11 Suppl. 3 1996 S89 S95
46. K.H. Sheehan, and D.V. Sheehan Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale Int. Clin. Psychopharmacol. 23 2008 70 83
47. D.V. Sheehan, A.L. Myers, A. Prakash, M.J. Robinson, m R.W. Swindle, J.M. Russell, and C.H. Mallinckrodt The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder Curr. Med. Res. Opin. 24 2008 2457 2466
48. G.E. Simon, D. Revicki, J. Heiligenstein, L. Grothaus, M. VonKorff, W.J. Katon, and T.R. Hylan Recovery from depression, work productivity and health care costs among primary care patients Gen. Hosp. Psychiatry 22 2000 153 162
49. G.E. Simon Social and economic burden of mood disorders Biol. Psychiatry 54 2003 208 215
50. S.M. Stahl, A. Malla, J.W. Newcomer, S.G. Potkin, P.J. Weiden, P.D. Harvey, A. Loebel, E. Watsky, C.O. Siu, and S. Romano A post-hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia, a 40-week, randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial J. Clin. Psychopharmacol. 30 2010 425 430
51. S.A. Strejilevich, D.J. Martino, E. Marengo, A. Igoa, G. Fassi, E.A. Whitham, and S.N. Ghaemi Long-term worsening of bipolar disorder related with frequency of antidepressant exposure Ann. Clin. Psychiatry 23 2011 186 192
52. S.M. Strakowski, P.E. Keck Jr., S.L. McElroy, S.A. West, K.J. Sax, J.M. Hawkins, G.F. Kmetz, V.H. Upadhyaya, K.C. Tugrul, and M.L. Bourne Twelve-month outcome after a first hospitalization for affective psychosis Arch. Gen. Psychiatry 55 1998 49 55
53. K. Suominen, E. Salminen, S. Lähteenmäki, T. Tupala, and E. Isometsä Validity and reliability of the Finnish version of the Functioning Assessment Short Test (FAST) in bipolar disorder Int J Bipolar Disord. 1 3 2015 10.1186/s40345-015-0025-1
54. T. Suppes, C. Datto, M. Minkwitz, A. Nordenhem, C. Walker, and D. Darko Effectiveness of extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. [corrected and republished article] J. Affect. Disord. 168 2014 485 493
55. M.E. Thase, W. Macfadden, R.H. Weisler, W. Chang, B. Paulsson, A. Kahn, and J.R. Calabrese Efficacy of quetiapine monotherapy in bipolar I and II depression, a double-blind, placebo-controlled study (the Bolder II Study) J. Clin. Psychopharmacol. 26 2006 600 609
56. M.E. Thase, A. Jonas, A. Khan, C.L. Bowden, X. Wu, R.D. McQuade, W.H. Carson, R.N. Marcus, and R. Owen Aripiprazole monotherapy in non-psychotic bipolar I depression, results of 2 randomized, placebo-controlled studies J. Clin. Psychopharmacol. 28 2008 13 20
57. M. Tohen, C.M. Waternaux, and M.T. Tsuang Outcome in mania, a 4-year prospective follow-up of 75 patients utilizing survival analysis Arch. Gen. Psychiatry 47 1990 1106 1111
58. M. Tohen, J. Hennen, C.M. Zarate Jr., R.J. Baldessarini, S.M. Strakowski, A.L. Stoll, G.L. Faedda, T. Suppes, P. Gebre-Medhin, and B.M. Cohen Two-year syndromal and functional recovery in 219 cases of first-episode major Affective disorder with psychotic features Am. J. Psychiatry 157 2000 220 228
59. M. Tohen, C.M. Zarate Jr., J. Hennen, H.-M.K. Khalsa, S.M. Strakowski, P. Gebre-Medhin, P. Salvatore, and R.J. Baldessarini The McLean-Harvard First-Episode Mania Study, prediction of recovery and first recurrence Am. J. Psychiatry 160 2003 2009 2107
60. M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowden, P.B. Mitchell, F. Centorrino, R. Risser, R.W. Baker, A.R. Evans, K. Beymer, S. Dube, G.D. Tollefson, and A. Breier Efficacy of olanzapine-fluoxetine in the treatment of bipolar I depression Arch. Gen. Psychiatry 60 2003 1079 1088
61. M. Tohen, E. Frank, C.L. Bowden, F. Colom, S.N. Ghaemi, L.N. Yatham, G.S. Malhi, J.R. Calabrese, W.A. Nolan, E. Vieta, F. Kapczinski, G.M. Goodwin, T. Suppes, G.S. Sachs, K.N.R. Chengappa, H. Grunze, P.B. Mitchell, S. Kanba, and M. Berk The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorder Bipolar Disord. 11 2009 453 473
62. M. Tohen, D.P. McDonnell, M. Case, S. Kanba, K. Ha, Y.R. Fang, H. Katagiri, and J.C. Gomez Randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression Br. J. Psychiatry 207 2012 376 382
63. A.P. Wingo, P.D. Harvey, and R.J. Baldessarini Neurocognitive impairment in bipolar disorder patients: functional implications Bipolar Disord. 11 2009 113 125
64. A.P. Wingo, R. Baldessarini, P.E. Holtzheimer, and P.D. Harvey Factors associated with functional recovery in bipolar disorder patients Bipolar Disord. 12 2010 319 326